BionTech CEO says will work with others to boost vaccine capacity - Anadolu

ANKARA (Reuters) - BioNTech Chief Executive Ugur Sahin said his company would be open to cooperating with others as it looks to increase production capacity for its COVID-19 vaccine developed with Pfizer and was considering opening an office in Turkey.

Reuters December 27, 2020 00:05:33 IST
BionTech CEO says will work with others to boost vaccine capacity - Anadolu

BionTech CEO says will work with others to boost vaccine capacity  Anadolu

ANKARA (Reuters) - BioNTech Chief Executive Ugur Sahin said his company would be open to cooperating with others as it looks to increase production capacity for its COVID-19 vaccine developed with Pfizer and was considering opening an office in Turkey.

Sahin repeated BioNTech aimed to distribute 1.3 billion doses of its vaccine by the end of 2021 and that 70% of the world needed to be vaccinated by next winter to go back to "normal life", according to an interview with Turkey's state-run Anadolu news agency.

"We want to produce more than 1 billion doses with Pfizer next year. We need to distribute them to over 80 countries," he was cited as saying. "This is not easy. Vaccines are made in a complex manner. We will start cooperating with other companies again," he added.

"If we can carry out our plans on how to increase capacity, we can disclose it in January or February. I believe we can increase it. We don't have a guaranteed plan yet."

Ankara has agreed to buy 4.5 million doses of the BioNTech and Pfizer vaccine, with an option to procure 30 million more doses later.

Sahin, the son of a Turkish immigrant to Germany, told Anadolu BioNTech was in talks with Turkey's state scientific agency Tubitak, and would aim to deliver the 30 million doses to the country by the end of 2021.

"It is a great joy to be able to help people in Turkey," Sahin was quoted as saying by Anadolu.

"We also want to carry out research in Turkey. We have talks with Tubitak, we have started working with some professors at universities. We want to open a branch of the BioNTech company in Turkey," he said, adding he hoped to start clinical work on cancer research in the country in the summer of 2021.

Turkey has also agreed to buy 50 million doses of China's Sinovac vaccine, CoronaVac, and a first shipment of 3 million doses of CoronaVac arrives on Monday.

(Reporting by Tuvan Gumrukcu; Editing by Alexandra Hudson)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Elon Musk leaves behind Amazon's Bezos to become world's richest person - Bloomberg News
Business

Elon Musk leaves behind Amazon's Bezos to become world's richest person - Bloomberg News

(Reuters) -Tesla Inc chief and billionaire entrepreneur Elon Musk surpassed Amazon.com Inc's top boss Jeff Bezos to become the world's richest man, Bloomberg News reported on Thursday.

Daimler starting year with optimism after strong finish to 2020 - CEO
Business

Daimler starting year with optimism after strong finish to 2020 - CEO

FRANKFURT (Reuters) - Daimler is starting the year with optimism after a strong finish to 2020, Chief Executive Ola Kaellenius said on Thursday, adding that sales in the fourth quarter had continued the strong trend seen in the preceding three months.

Oil hits 11-month highs on Saudi cuts, shrugs off U.S. unrest
Business

Oil hits 11-month highs on Saudi cuts, shrugs off U.S. unrest

By Laura Sanicola NEW YORK (Reuters) -Oil prices edged higher on Thursday, hitting 11-month peaks as markets remained focused on Saudi Arabia's unexpected pledge to deepen its oil cuts and firmer equities, shrugging off political unrest in the United States. Brent crude rose 18 cents to $54.48 a barrel by 1:32 p.m. EST (1832 GMT) after touching $54.90, a high not seen since before the first COVID-19 lockdowns in the West.